FDA accepts AcelRx pain drug delivery tech for review; Researchers deliver drugs through membrane in the ear;

> AcelRx Pharmaceuticals ($ACRX) is hoping for an approval date in September next year after the FDA accepted its pain drug delivery system for regulatory review this week. More

> Researchers at the Rochester Institute of Technology have developed a delivery method for drugs via absorption through the round window membrane in the ear. Abstract

> Zogenix ($ZGX) and Batelle signed a 5-year contract for the use of Zogenix's DosePro needle-free drug delivery technology. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.